AR222, AR249, AS274, AS702 and AS708 antibodies recognize the spike S protein from SARS-CoV-2 by immunofluorescence
DOI:
https://doi.org/10.24450/journals/abrep.2020.e228Abstract
The recombinant antibodies AR222, AR249, AS274, AS702 and AS708 detect by immunofluorescence the spike S protein from SARS-CoV-2.
Downloads
References
Marchetti A, Hammel P, Zenhausern F. AI334, AQ806 and RB596 antibodies recognize the spike S protein from SARS-CoV-2 by immunofluorescence. Antib. Rep. 2020, 3:e219. doi:10.24450/journals/abrep.2020.e219
Seydoux E, Homad LJ, MacCamy AJ, et al. Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity 2020; 53:1-8. PMID: 32561270.
Walter JD, Hutter CAJ, Zimmermann I, et al. Sybodies targeting the SARS-CoV-2 receptor-binding domain. Preprint. bioRxiv 2020; 2020.04.16.045419. doi:10.1101/2020.04.16.045419
Wrapp D, De Vlieger D, Corbett KS, et al. Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies. Cell 2020; 181:1004-1015. PMID:32375025
Wu Y, Wang F, Shen C, et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 2020; 368:1274-1278. PMID:32404477
Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 2020; 367:1444-1448. PMID:32132184
Downloads
Published
Versions
- 2023-03-03 (2)
- 2020-07-13 (1)
How to Cite
Issue
Section
License
Copyright (c) 2020 The author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
